The FDA has approved Rhapsido (remibrutinib) for adults with symptomatic dermographism who remain symptomatic despite use of ...

Scars and all, three women who had breast cancer learn how to grieve their old self and give their new one grace. They share ...

Three breast cancer survivors share their emotional stories, from diagnosis and treatment to remission. Plus the best advice ...

The FDA has approved Tukysa (tucatinib) combined with trastuzumab and pertuzumab for the maintenance treatment of adult ...

The FDA has approved Jaypirca (pirtobrutinib) for adults with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma without a 17p deletion.

The FDA has approved Atebrioz (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification in adults and pediatric patients aged 12 years or older with fibrodysplasia ossificans ...